This inventor holds 4 USPTO granted patents and 6 published patent applications. Top assignees: Point Biopharma Inc., Centre for Probe Development and Commercialization. Active years: 2021-2026.
Company Filing History:
3 out of 3 
1 out of 5 Years Active: 2021-2026
Title: Joe McCann: Innovator in Radiopharmaceuticals
Introduction
Joe McCann is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative compounds and methods that enhance treatment options in medicine.
Latest Patents
One of Joe McCann's latest patents is related to a radiopharmaceutical known as Lu-PSMA I&T. This compound is provided in high purities with an extended shelf life. The patent also includes methods for synthesizing Lu-PSMA I&T, along with pharmaceutical compositions and treatment methods that incorporate this compound. Another significant patent involves a radiopharmaceutical compound called Lu-DOTATATE. This patent encompasses a composition and a kit, as well as methods for synthesizing Lu-DOTATATE and treatment methods that utilize this compound.
Career Highlights
Throughout his career, Joe McCann has worked with several prominent organizations. He has been associated with Point Biopharma Inc. and the Centre for Probe Development and Commercialization. His experience in these companies has allowed him to contribute to the advancement of radiopharmaceutical technologies.
Collaborations
Joe has collaborated with several professionals in his field, including Justyna Kelly and Paul Billone. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Joe McCann is a distinguished inventor whose work in radiopharmaceuticals has led to significant advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through technology.